abstract |
The present invention relates generally to a series of compounds, pharmaceutical compositions containing the compounds and the use of such compounds and compositions as therapeutic agents. More specifically, the compounds of the present invention are hexahydroazepinoindole compounds and octahydroazepinoindole compounds. These compounds are ligands for serotonin receptors (5-HT) and treat diseases, disorders and conditions (eg, anxiety, depression and obesity) where modulation of serotonin receptor (5-HT) activity is desired. Useful for. |